Edition:
United States

Supernus Pharmaceuticals Inc (SUPN.OQ)

SUPN.OQ on NASDAQ Stock Exchange Global Market

57.05USD
22 Jun 2018
Change (% chg)

-- (--)
Prev Close
$57.05
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
205,657
52-wk High
$61.10
52-wk Low
$33.45

Chart for

About

Supernus Pharmaceuticals, Inc. is a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases. The Company offers Oxtellar XR (extended-release oxcarbazepine) and Trokendi XR (extended-release topiramate), its two treatments for patients with epilepsy. In... (more)

Overall

Beta: 1.05
Market Cap(Mil.): $2,954.99
Shares Outstanding(Mil.): 51.80
Dividend: --
Yield (%): --

Financials

  SUPN.OQ Industry Sector
P/E (TTM): 37.71 29.56 34.14
EPS (TTM): 1.51 -- --
ROI: 17.13 13.56 13.10
ROE: 29.05 15.35 15.09

BRIEF-Supernus Pharma Reports Q1 Earnings Per Share $0.49

* SUPERNUS ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS AND RECORD QUARTERLY REVENUE

May 08 2018

BRIEF-Supernus Announces Pricing Of $350 Mln Private Offering Of 0.625 Pct Convertible Senior Notes

* SUPERNUS ANNOUNCES PRICING OF $350 MILLION PRIVATE OFFERING OF 0.625% CONVERTIBLE SENIOR NOTES

Mar 15 2018

BRIEF-Supernus Announces Proposed Private Offering Of $350 Million Of Convertible Senior Notes

* SUPERNUS ANNOUNCES PROPOSED PRIVATE OFFERING OF $350 MILLION OF CONVERTIBLE SENIOR NOTES

Mar 13 2018

BRIEF-Supernus Reports Q4 Earnings Per Share ‍$0.26​

* SUPERNUS ANNOUNCES RECORD FULL YEAR 2017 FINANCIAL RESULTS, EXCEEDING OPERATING EARNINGS GUIDANCE

Feb 27 2018

Competitors

  Price Chg
Abbott Laboratories (ABT.N) $61.94 +0.19
AstraZeneca plc (AZN.L) 5,252.00 +23.00
Eli Lilly And Co (LLY.N) $85.92 -0.15
Shire PLC (SHP.L) 4,101.00 +35.00
Shire PLC (3159084.L) -- --
Smiths Group plc (SMIN.L) 1,686.50 -41.50

Earnings vs. Estimates